HL7 FHIR® Implementation Guide: Standardized Medication Profile (SMP), Edition 1 - US Realm

DESCRIPTION

The HL7 FHIR Standardized Medication Profile (SMP) Implementation Guide defines a way to transmit medication/drug information (as prescription or orders or records of a patient receiving some kind of medication/drug). As a patient travels through the healthcare system (such as from hospital to nursing facility to home) this guide shows how the medication/drug information can be sent electronically with the patient to enable medication reconciliation.

See the specification at http://hl7.org/fhir/us/smp/STU1.

ALTERNATIVE NAMES

HL7 FHIR® Implementation Guide: Standardized Medication Profile (SMP), Edition 1 - US Realm may also go by the following names or acronyms:

BENEFITS

• Identifies and defines the components of an interoperable medication profile for clinicians, patients and caregivers to use for the exchange of essential medication information
• Enables the medication reconciliation process with the best available data.

IMPLEMENTATIONS/CASE STUDIES

• This Implementation Guide is joint HL7 and NCPDP balloted in response to study by Joint Commission 2021 National Patient Safety Goals Effective January 2021 for the Hospital Program

DEVELOPMENT BACKGROUND

Following a number of studies of adverse events, a white paper was jointly developed by HL7 and NCPDP: HL7/NCPDP Informative Document: Standardized Medication Profile. Based on the white paper a project was created, funded by Pfizer to produce a US Realm FHIR Implementation Guide. The project was created as a stand-alone exercise but was aligned and operated under the umbrella of the PACIO projects. This Implementation Guide forms part of the related PACIO IGs.

RELATED DOCUMENTS

HL7 FHIR® Implementation Guide: Standardized Medication Profile (SMP), Edition 1 - US Realm

STU DOCUMENTS

HL7 FHIR® Implementation Guide: Standardized Medication Profile (SMP), Edition 1 - US Realm See the standard at http://hl7.org/fhir/us/smp/STU1.

(Submit Feedback on STU)

ADDITIONAL DETAILS

This implementation identifies and defines the components of an interoperable medication profile for clinicians, patients and caregivers to use for the exchange of essential medication information. These exchanges are vitally important to the patient's well-being during transitions of care to and from post-acute care settings but are also applicable to many situations. The key benefit of this implementation guide is to enable the medication reconciliation process with the best available data.

TOPIC

• Pharmacy

BALLOT TYPE

• STU

STATUS DATE

2025-05-16

RESPONSIBLE WORK GROUP

PRODUCT TYPE

• Implementation Guide

STAKEHOLDERS

• EHR, PHR Vendors
• Healthcare Institutions
• Pharmaceutical Vendors
• Standards Development Organizations (SDOs)

FAMILY

• FHIR

CURRENT STATE

• Active

REALM

• US Realm